STSwapnali A. Thorat

Swapnali A. Thorat

*This is an algorithmically generated author record based on publicly available information.

Swapnali A. Thorat has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Design and Evaluation of Phyto-phospholipid Complexes of Selected Polyherbal Churna Extracts for Anticancer Activity

    by Sangram Subhash Patil, Kishor B. Burade, Swapnali V. Dharanguttikar, Ganesh H. Wadkar, Sangram S. Madane, Ashish A. Misal, Prajakta S. Patil

    Background: Cancer continues to be a global health problem today. Traditional chemotherapy, which is commonly used in the treatment of cancer, has problems like low bioavailability, systemic toxicity, and drug resistance. Polyherbal formulations provide synergistic therapeutic advantages, whereas phyto-phospholipid complexation improves the solubility, permeability, and bioavailability of phytoconstituents. Aim: To develop and evaluate phyto-phospholipid complexes from a specific polyherbal churna extract that includes Picrorhiza kurroa, Bauhinia variegata, and Curcuma longa to boost their anticancer effects. Methods: A hydroalcoholic extract of polyherbal churna was prepared by maceration. Phyto-phospholipid complexes were prepared using the solvent evaporation method at different drug-phospholipid ratios (1:1, 1:2, and 1:3). Particle size analysis, Fourier Transform Infrared Spectroscopy (FTIR), X-Ray Diffraction (XRD), Digital Signature Certificate (DSC), and zeta potential determination were used to characterise the optimised complex. The DPPH and ABTS tests were used to see how well the antioxidants worked. The MTT assay was used to assess how toxic the cells were to HeLa, MCF-7, and A549 cancer cell lines. Results: Enhanced solubility and entrapment efficiency of 78.45 ± 2.3% were demonstrated by the optimised phyto-phospholipid complex (1:2 ratios). Complex formation was verified by FTIR and DSC. With IC50 values of 24.8 ± 1.5 μg/mL (DPPH) and 28.3 ± 1.8 μg/mL (ABTS), the complex outperformed crude extract in terms of antioxidant activity (IC50: 45.2 ± 2.1 and 52.6 ± 2.4 μg/mL, respectively). Comparing the complex to crude extract, cytotoxicity studies showed significantly lower IC50 values against MCF-7 (32.5 ± 2.1 μg/mL), HeLa (38.7 ± 2.5 μg/mL), and A549 (42.3 ± 2.8 μg/mL). Conclusion: Polyherbal churna extract phyto-phospholipid complexes showed increased antioxidant and cytotoxic potential, suggesting potential for cancer treatment and calling for additional in vivo research. Major Findings: The optimized complex (1:2 ratio) showed 5-fold enhanced solubility, 45% stronger antioxidant activity (IC₅₀: 24.8 vs 45.2 μg/mL), and two-fold improved cytotoxicity against cancer cell lines (IC₅₀: 32.5-42.3 vs 68.5-82.7 μg/mL) compared to crude extract, as confirmed by comprehensive characterization (FTIR, DSC, XRD, SEM, TEM).

  • Synthesis, In-Silico Potential Enzymatic Target Predictions, Pharmacokinetics, Toxicity, Anti-Microbial and Anti-Inflammatory Studies of Bis-(2-methylindolyl) Methane Derivatives

    by Dnyaneshwar T. Nagre, Suraj N. Mali, Bapu R. Thorat, Swapnali A. Thorat, Atul R. Chopade, Mazhar Farooqui, Brijmohan Agrawal

    Background: The bis(indolyl)methanes (BIMs) scaffold is reported for wide varieties of pharmacological profiles, including antibacterial, anti-proliferative, anticancer, cytotoxic, insecticidal, analgesic, antioxidant, and anti-inflammatory agents. Materials and Methods: A series of bis(indolyl)methanes have been synthesized by a greener and newer approach using the reaction of different substituted aldehydes and indole in the presence of an easily available and biodegradable base such as piperidine in acetic acid at room temperature and characterized with ultraviolet–visible spectrophotometry (UV–Vis or UV/Vis), Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance spectroscopy (NMR), etc. The antibacterial and antifungal activities were also carried out against Staphylococcus aureus (RCMB 000106) and Bacillis subtilis (RCMB 000107), as two Gram-positive bacterial strains, and Salmonella typhi and Escherichia coli (RCMB 000103), as two Gram-negative bacterial strains. Fungal species such as Candida Albicans, Penicillium chrysogenum, Aspergillus niger were also used for in vitro antifungal evaluation. All our newly synthesized 14 compounds (4a-4n) were subjected for anti-inflammatory activity in vitro and compared with the known standard drug aceclofenac. Results: Our newly synthesized compounds showed good to moderate antibacterial agents, in silico ADMET, and anti-inflammatory profiles. Conclusion: We hope that our current study would aid future developments of bis(indolyl)methanes as antibacterial and anti-inflammatory agents.


  • In-silico Evaluation of Wound Healing Potential of Euphorbia tithymaloides

    by Rahul S. Adnaik, Vyankatesh R. Dharang, Swapnali A. Thorat, Pratibha R. Adnaik, Prajakta D. Nayakal, Sanket S. Patil

    In-silico Evaluation of Wound Healing Potential of Euphorbia tithymaloides